# Tolo Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tolo-biotech-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: http://www.tolobio.com
- Latest round: Angel (Aug 4, 2020)
- Investors on record: 1

## About

Established in 2013 and based in Shanghai, China, Tolo Biotech Co.,Ltd operates as a biotechnology company dedicated to providing molecule diagnostic service. It established offices in Wuxi, Anhui, and America. In August 2020, Tolo Biotech Co.,Ltd closed angel funding from new investor BGI Co-WIN Investment Management.

The company mainly provides scientific research reagents and molecular diagnostic reagents. The scientific research reagents include CRISPR (clustered regularly interspaced short palindromic repeats), PCR (polymerase chain reaction), nucleic acid extraction, and other products. The molecular diagnostic reagents include CRISPR and PCR. Tolo Biotech Co.,Ltd also provides cloning-related vectors and reagents, Next Generation Sequencing library construction-related kits, and a variety of molecular biology enzymes.

## Funding rounds

- Angel, Aug 4, 2020 — BGI Co-WIN Investment Management

## Investors

- BGI Co-WIN Investment Management (https://capitalatlas.ai/funds/bgi-co-win-investment-management) — Angel